MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41586-025-08974-4

Медицинская библиотека · Nature · 2025

Activation of lysosomal iron triggers ferroptosis in cancer.

Cañeque Tatiana, Baron Leeroy, Müller Sebastian, Carmona Alanis, Colombeau Ludovic, Versini Antoine, Solier Stéphanie, Gaillet Christine, Sindikubwabo Fabien, Sampaio Julio L, Sabatier Marie, Mishima Eikan, Picard-Bernes Armel, Syx Laurène, Servant Nicolas, Lombard Bérangère, Loew Damarys, Zheng Jiashuo, Proneth Bettina, Thoidingjam Leishemba K, Grimaud Laurence, Fraser Cameron S, Szylo Krystina J, Der Kazarian Emma, Bonnet Caroline, Charafe-Jauffret Emmanuelle, Ginestier Christophe, Santofimia-Castaño Patricia, Estaras Matias, Dusetti Nelson, Iovanna Juan Lucio, Cunha Antonio Sa, Pittau Gabriella, Hammel Pascal, Tzanis Dimitri, Bonvalot Sylvie, Watson Sarah, Gandon Vincent, Upadhyay Aditya, Pratt Derek A, Freitas Florêncio Porto, Friedmann Angeli José Pedro, Stockwell Brent R, Conrad Marcus, Ubellacker Jessalyn M, Rodriguez Raphaël

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Iron catalyses the oxidation of lipids in biological membranes and promotes a form of cell death called ferroptosis1. Defining where this chemistry occurs in the cell can inform the design of drugs capable of inducing or inhibiting ferroptosis in various disease-relevant settings. Genetic approaches have revealed suppressors of ferroptosis2-4; by contrast, small molecules can provide spatiotemporal control of the chemistry at work5. Here we show that the ferroptosis inhibitor liproxstatin-1 exerts cytoprotective effects by inactivating iron in lysosomes. We also show that the ferroptosis inducer RSL3 initiates membrane lipid oxidation in lysosomes. We designed a small-molecule activator of lysosomal iron-fentomycin-1-to induce the oxidative degradation of phospholipids and ultimately ferroptosis. Fentomycin-1 is able to kill iron-rich CD44high primary sarcoma and pancreatic ductal adenocarcinoma cells, which can promote metastasis and fuel drug tolerance. In such cells, iron regulates cell adaptation6,7 while conferring vulnerability to ferroptosis8,9. Sarcoma cells exposed to sublethal doses of fentomycin-1 acquire a ferroptosis-resistant cell state characterized by the downregulation of mesenchymal markers and the activation of a membrane-damage response. This phospholipid degrader can eradicate drug-tolerant persister cancer cells in vitro and reduces intranodal tumour growth in a mouse model of breast cancer metastasis. Together, these results show that control of iron reactivity confers therapeutic benefits, establish lysosomal iron as a druggable target and highlight the value of targeting cell states10.

Для цитирования: Cañeque Tatiana, Baron Leeroy, Müller Sebastian, Carmona Alanis, Colombeau Ludovic, Versini Antoine, Solier Stéphanie, Gaillet Christine, Sindikubwabo Fabien, Sampaio Julio L, Sabatier Marie, Mishima Eikan, Picard-Bernes Armel, Syx Laurène, Servant Nicolas, Lombard Bérangère, Loew Damarys, Zheng Jiashuo, Proneth Bettina, Thoidingjam Leishemba K, Grimaud Laurence, Fraser Cameron S, Szylo Krystina J, Der Kazarian Emma, Bonnet Caroline, Charafe-Jauffret Emmanuelle, Ginestier Christophe, Santofimia-Castaño Patricia, Estaras Matias, Dusetti Nelson, Iovanna Juan Lucio, Cunha Antonio Sa, Pittau Gabriella, Hammel Pascal, Tzanis Dimitri, Bonvalot Sylvie, Watson Sarah, Gandon Vincent, Upadhyay Aditya, Pratt Derek A, Freitas Florêncio Porto, Friedmann Angeli José Pedro, Stockwell Brent R, Conrad Marcus, Ubellacker Jessalyn M, Rodriguez Raphaël. Activation of lysosomal iron triggers ferroptosis in cancer.. Nature. 2025. DOI: 10.1038/s41586-025-08974-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.